Industry Verticals »

All Categories

Insights »

About TMR »

Multiplexed Diagnostics Market Insights, 2019-2027

Multiplexed Diagnostics Market (Technologies - Very High Density, High Density, Medium Density, Low Density, and Next Generation Sequencing Assays; Applications - Infectious Disease Diagnostics, Oncology, Autoimmune Diseases, Cardiac Diseases, and Allergies; End Users - Academic Research Institutes, Hospitals, Pharmaceuticals Companies, Clinical Research Organizations, and Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global multiplexed diagnostics market for the historical period 2017–2018 and forecast period 2019–2027, rise in private and public funding for genomics and personalized medicine and growing demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases are projected to drive the global multiplexed diagnostics market during the forecast period
  • According to the report, the global multiplexed diagnostics market was valued at US$ 8.7 Bn in 2018 and is anticipated to grow at a CAGR of 17.9% from 2019 to 2027
global fa multiplexed diagnostics market

To know the scope of our report Get a Sample on Multiplexed Diagnostics Market

Rise in private and public funding for genomics and personalized medicine: Key Driver

  • Significant private and public funding for genomics and personalized medicine is a key factor driving the global multiplexed diagnostics market.
  • For instance, the Europa Organization supports innovative companies in the development of new products. Blood Cancer Research Fund provided financial assistance to the University of California San Diego (UCSD) to study the effect of PCR duplicates in deep sequencing experiments and potential biasing. In September 2014, UCSD published results in the journal of Genome Biology.
  • Furthermore, growing demand for automated equipment & multifaceted analytical strategies and rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases
  • Moreover favorable regulatory scenario for new product launch and multiple usage of multiplexed diagnostics technology are some of the major factors responsible for the growth of global multiplexed diagnostics market.

Get a glimpse of the in-depth analysis through our Report Brochure

High cost associated with multiplexed diagnostics assay hamper the market growth

  • Lack of skilled labor and high cost associated with multiplexed diagnostics assay can restrain the market growth.
  • Moreover Reimbursement structure for diagnostics test that uses multiplexed assays is unclear by private as well as public payers as compared to conventional diagnostic tests which can restrain the global multiplexed diagnostics market

Global multiplexed diagnostics Market: North America dominated the global market

  • On the basis of region, the multiplexed diagnostics market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
  • North America region dominated the global market owing sequencing along with higher awareness, significant health care spending in overall national budgets, early availability of advanced technologies, and higher penetration of research activities across the country.
  • However, Asia-Pacific region is considered as the most lucrative market during the forecast period from 2019 to 2027. The growth is mainly ascribed to factors such as developing countries such as China and India offer lucrative growth prospects in the multiplexed diagnostics market due to factors such as improving health care infrastructure, rising private and public investment in life science research, and technological advancements.

Global Multiplexed diagnostics Market: Competitive Landscape

  • This report profiles major players in the global multiplexed diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global multiplexed diagnostics market is highly consolidated, with a few global players accounting for a major share in market.
  • Leading players operating in the global multiplexed diagnostics market are
    • Agilent Technologies
    • bioMérieux SA
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • F. Hoffmann-La Roche Ltd.,
    • Hologic, Inc.
    • Luminex Corporation
    • Siemens Healthineers
    • Thermo Fisher Scientific, Inc.
    • Abbott Laboratories

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Multiplexed diagnostics Market: Key Developments

Key players in the global multiplexed diagnostics market are engaged in regulatory approvals, new product development, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global multiplexed diagnostics market. A few expansion strategies adopted by players operating in the global Multiplexed diagnostics market are:

  • On May 7, 2020, Eurofins Technologies has launched of its RT-PCR (polymerase chain reaction to reverse transcriptase chain reaction) CE-IVD marked multiplex for direct qualitative detection of the pathogen of the new coronavirus (SARS-CoV-2).
  • On April 21, 2020, Health Science Authority (HSA) in Singapore has approved Thermo Fisher Scientific a provisionallly authorization for the Applied Biosystems TaqPath COVID-19 Combo Kit
  • The report on the global multiplexed diagnostics market discussed individual strategies, followed by company profiles of manufacturers of multiplexed diagnostics. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global multiplexed diagnostics market.

Global Multiplexed Diagnostics market – Segmentation

Technology
  • Very High Density Multiplexed Assays
  • High Density Multiplexed Assays
  • Medium Density Multiplexed Assays
  • Low Density Multiplexed Assays
  • Next Generation Sequencing

Application
  • Infectious Disease Diagnosis
  • Oncology
  • Autoimmune Diseases
  • Cardiac Diseases
  • Allergies
  • Others

End-user
  • Academic Research Institutes
  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical Companies
  • Clinical Research Organizations

Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of multiplexed diagnostics market?

The global multiplexed diagnostics market was worth US$ 8.7 Bn and is projected to reach a value of US$ 39.8 Bn by the end of 2027

What is the anticipated CAGR of the multiplexed diagnostics market in the forecast period?

Multiplexed diagnostics market is anticipated to grow at a CAGR of 17.9% during the forecast period

Which region is expected to project the highest market share in the global multiplexed diagnostics market?

North America accounted for a major share of the global multiplexed diagnostics market

What are the key driving factors for the growth of the multiplexed diagnostics market?

Rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases is the major factor to drive the global multiplexed diagnostics market

Who are the key players in the global multiplexed diagnostics market?

Key players in the global multiplexed diagnostics market include Agilent Technologies, bioMérieux SA, Bio-Rad Laboratories, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Luminex Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., Abbott Laboratories

    1. Preface 

        1.1. Report Scope and Market Segmentation 

        1.2. Research Highlights

    2. Assumptions and Research Methodology 

        2.1. Assumptions

        2.2. Acronyms Used

        2.3. Research Methodology

    3. Executive Summary

        3.1. Global Multiplexed Diagnostics Market Snapshot 

    4. Market Overview

        4.1. Product Overview

        4.2. Demographics & Market Indicators 

        4.3. Key Industry Events 

        4.4. Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, 2017–2027

        4.5. Global Multiplexed Diagnostics Market Outlook 

        4.6. Porter's Five Forces Analysis

    5. Market Dynamics

        5.1. Drivers and Restraints Snapshot Analysis

        5.2. Drivers

        5.3. Restraints

        5.4. Opportunities

    6. Global Multiplexed Diagnostics Market Analysis, by Technology

        6.1. Introduction

        6.2. Key Findings

        6.3. Global Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2017-2027 

            6.3.1. Very High Density Multiplexed Assays (> 10,000-plex)

            6.3.2. High Density Multiplexed Assays (500 ≤ plex ≤ 10,000)

            6.3.3. Medium Density Multiplexed Assays (plex < 500)

            6.3.4. Low Density Multiplexed Assays (plex ≤ 5)

            6.3.5. Next Generation Sequencing Assays

        6.4. Global Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2019–2027

        6.5. Key Trends

    7. Global Multiplexed Diagnostics Market Analysis, by Application

        7.1. Introduction

        7.2. Key Findings

        7.3. Global Multiplexed Diagnostics Market Value Share Analysis, by Application, 2017 -2027

            7.3.1. Infectious Disease Diagnostic

            7.3.2. Oncology

            7.3.3. Autoimmune Diseases

            7.3.4. Cardiac Diseases

            7.3.5. Allergies

            7.3.6. Others (pregnancy & fertility testing, etc.)

        7.4. Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2019-2027

        7.5. Key Trends

    8. Global Multiplexed Diagnostics Market Analysis, by End User

        8.1. Introduction

        8.2. Key Findings

        8.3. Global Multiplexed Diagnostics Market Value Share Analysis, by End-user 2017-2027

            8.3.1. Academic Research Institutes

            8.3.2. Hospitals

            8.3.3. Pharmaceutical Companies

            8.3.4. Clinical Research Organizations

            8.3.5. Diagnostic Laboratories

        8.4. Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2019-2027

        8.5. Key Trends

    9. Global Multiplexed Diagnostics Market Analysis, by Region

        9.1. Global Market Scenario by Country

        9.2. Global Multiplexed Diagnostics Market Value Share Analysis, by Region, 2016 and 2024 

    10. North America Multiplexed Diagnostics Market Analysis

        10.1. Key Findings

        10.2. Market Overview

        10.3. North America Multiplexed Diagnostics Market Value Share Analysis, by Country

        10.4. North America Multiplexed Diagnostics Market Value Share Analysis, by Technology 

        10.5. North America Multiplexed Diagnostics Market Value Share Analysis, by Application 

        10.6. North America Multiplexed Diagnostics Market Value Share Analysis, by End User 

        10.7. North America Multiplexed Diagnostics Market Attractiveness Analysis 

        10.8. North America Multiplexed Diagnostics Market Trends 

    11. Europe Multiplexed Diagnostics Market Analysis

        11.1. Key Findings

        11.2. Market Overview

        11.3. Europe Multiplexed Diagnostics Market Value Share Analysis, by Country

        11.4. Europe Multiplexed Diagnostics Market Value Share Analysis, by Technology 

        11.5. Europe Multiplexed Diagnostics Market Value Share Analysis, by Application 

        11.6. Europe Multiplexed Diagnostics Market Value Share Analysis, by End User 

        11.7. Europe Multiplexed Diagnostics Market Attractiveness Analysis 

        11.8. Europe Multiplexed Diagnostics Market Trends 

    12.  Asia Pacific Multiplexed Diagnostics Market Analysis

        12.1. Key Findings

        12.2. Market Overview

        12.3. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Country

        12.4. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Technology 

        12.5. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Application 

        12.6. Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by End User 

        12.7. Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis 

        12.8. Asia Pacific Multiplexed Diagnostics Market Trends 

    13. Latin America Multiplexed Diagnostics Market Analysis

        13.1. Key Findings

        13.2. Market Overview

        13.3. Latin America Multiplexed Diagnostics Market Value Share Analysis, by Country

        13.4. Latin America Multiplexed Diagnostics Market Value Share Analysis, by Technology 

        13.5. Latin America Multiplexed Diagnostics Market Value Share Analysis, by Application 

        13.6. Latin America Multiplexed Diagnostics Market Value Share Analysis, by End User 

        13.7. Latin America Multiplexed Diagnostics Market Attractiveness Analysis 

        13.8. Latin America Multiplexed Diagnostics Market Trends 

    14. Middle East & Africa Multiplexed Diagnostics Market Analysis

        14.1. Key Findings

        14.2. Market Overview

        14.3. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Country

        14.4. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Technology 

        14.5. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Application 

        14.6. Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by End User 

        14.7. Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis 

        14.8. Middle East & Africa Multiplexed Diagnostics Market Trends 

    15. Competition Landscape

        15.1. Multiplexed Diagnostics Market Share Analysis By Company, 2018

        15.2.  Competition Matrix

        15.3. Company Profiles

            15.3.1. Agilent Technologies

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Company Financials

                15.3.1.3. Growth Strategies

                15.3.1.4. SWOT Analysis

            15.3.2. bioMérieux SA

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Company Financials

                15.3.2.3. Growth Strategies

                15.3.2.4. SWOT Analysis

            15.3.3. Bio-Rad Laboratories, Inc.

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Company Financials

                15.3.3.3. Growth Strategies

                15.3.3.4. SWOT Analysis

            15.3.4. Illumina, Inc.

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Company Financials

                15.3.4.3. Growth Strategies

                15.3.4.4. SWOT Analysis

            15.3.5. F. Hoffmann-La Roche Ltd.

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Company Financials

                15.3.5.3. Growth Strategies

                15.3.5.4. SWOT Analysis

            15.3.6. Hologic, Inc.

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Company Financials

                15.3.6.3. Growth Strategies

                15.3.6.4. SWOT Analysis

            15.3.7. Luminex Corporation

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Company Financials

                15.3.7.3. Growth Strategies

                15.3.7.4. SWOT Analysis

            15.3.8. Siemens Healthineers

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Company Financials

                15.3.8.3. Growth Strategies

                15.3.8.4. SWOT Analysis

            15.3.9. Thermo Fisher Scientific, Inc.

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Company Financials

                15.3.9.3. Growth Strategies

                15.3.9.4. SWOT Analysis

            15.3.10. Abbott Laboratories 

                15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.10.2. Company Financials

                15.3.10.3. Growth Strategies

                15.3.10.4. SWOT Analysis

    List of Tables

    Table 1: Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2027

    Table 2: Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2027

    Table 3: Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 4: Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2027

    Table 5: North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 6: North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2027

    Table 7: North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2027

    Table 8: North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 9: Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 10: Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2027

    Table 11: Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2027

    Table 12: Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 13: Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 14: Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2027

    Table 15: Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2027

    Table 16: Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 17: Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 18: Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2027

    Table 19: Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2027

    Table 20: Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 21: Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 22: Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017–2027

    Table 23: Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2027

    Table 24: Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast, by End-user,2017–2027

    List of Figures

    Figure 1: Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, 2017–2027

    Figure 2: Multiplexed Diagnostics Market Value Share, by Application (2018)

    Figure 3: Multiplexed Diagnostics Market Value Share, by Region (2018)

    Figure 4: Multiplexed Diagnostics Market Value Share, by Technology (2018)

    Figure 5: Multiplexed Diagnostics Market Value Share, by End-user (2018)

    Figure 6: Global Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027

    Figure 7: Global Very High Density Multiplexed Assays (> 10,000-plex) Market Revenue (US$ Mn), 2017–2027

    Figure 8: Global High Density Multiplexed Assays (500 ≤ plex ≤ 10,000) Market Revenue (US$ Mn), 2017–2027

    Figure 9: Global Medium Density Multiplexed Assays (plex < 500) Market Revenue (US$ Mn), 2017–2027

    Figure 10: Global Low Density Multiplexed Assays (plex ≤ 5) Market Revenue (US$ Mn), 2017–2027

    Figure 11: Global Next Generation Sequencing Assays Market Revenue (US$ Mn), 2017–2027

    Figure 12: Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2019–2027

    Figure 13: Global Multiplexed Diagnostics Market Value Share Analysis, by Application, 2018 and 2027

    Figure 14: Global Infectious Disease Diagnostic Market Revenue (US$ Mn), 2017–2027

    Figure 15: Global Oncology Market Revenue (US$ Mn), 2017–2027

    Figure 16: Global Infectious Disease Diagnostic Market Revenue (US$ Mn), 2017–2027

    Figure 17: Global Cardiac Diseases Market Revenue (US$ Mn), 2017–2027

    Figure 18: Global Allergies Market Revenue (US$ Mn), 2017–2027

    Figure 19: Global Others Market Revenue (US$ Mn), 2017–2027

    Figure 20: Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2017–2027

    Figure 21: Global Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 22: Global Academic Research Institutes Market Revenue (US$ Mn), 2014-2024

    Figure 23: Global Hospitals Market Revenue (US$ Mn), 2017–2027

    Figure 24: Global Pharmaceutical Companies Market Revenue (US$ Mn), 2017–2027

    Figure 25: Global Clinical Research Organizations Market Revenue (US$ Mn), 2017–2027

    Figure 26: Global Diagnostic Laboratories Market Revenue (US$ Mn), 2017–2027

    Figure 27: Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2016-2024

    Figure 28: Global Multiplexed Diagnostics Market Value Share Analysis, by Region, 2018 and 2027

    Figure 29: Global Multiplexed Diagnostics Market Attractiveness Analysis, by Region, 2017–2027

    Figure 30: North America Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    Figure 31: North America Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2019–2027

    Figure 32: North America Multiplexed Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

    Figure 33: North America Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027

    Figure 34: North America Multiplexed Diagnostics Market Value Share Analysis, by Application, 2018 and 2027

    Figure 35: North America Multiplexed Diagnostics Market Value Share Analysis, by End User, 2018 and 2027

    Figure 36: North America Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2019–2027

    Figure 37: North America Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2019–2027

    Figure 38: North America Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 39: Europe Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    Figure 40: Europe Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2019–2027

    Figure 41: Europe Multiplexed Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

    Figure 42: Europe Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027

    Figure 43: Europe Multiplexed Diagnostics Market Value Share Analysis, by Application, 2018 and 2027

    Figure 44: Europe Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 45: Europe Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2019–2027

    Figure 46: Europe Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2019–2027

    Figure 47: Europe Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 48: Asia Pacific Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    Figure 49: Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2019–2027

    Figure 50: Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

    Figure 51: Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027

    Figure 52: Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by Application, 2018 and 2027

    Figure 53: Asia Pacific Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 54: Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2019–2027

    Figure 55: Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2019–2027

    Figure 56: Asia Pacific Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 57: Latin America Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    Figure 58: Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2019–2027

    Figure 59: Latin America Multiplexed Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

    Figure 60: Latin America Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027

    Figure 61: Latin America Multiplexed Diagnostics Market Value Share Analysis, by Application, 2018 and 2027

    Figure 62: Latin America Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 63: Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2019–2027

    Figure 64: Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2019–2027

    Figure 65: Latin America Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 66: Middle East & Africa Multiplexed Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027

    Figure 67: Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by Country, 2019–2027

    Figure 68: Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

    Figure 69: Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027

    Figure 70: Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by Application, 2018 and 2027

    Figure 71: Middle East & Africa Multiplexed Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 72: Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2019–2027

    Figure 73: Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2019–2027

    Figure 74: Middle East & Africa Multiplexed Diagnostics Market Attractiveness Analysis, by End-user, 2019–2027

    Figure 75: Global Multiplexed Diagnostics Market Share Analysis, by Company, 2016 (Estimated)

Copyright © Transparency Market Research, Inc. All Rights reserved

Multiplexed Diagnostics Market Insights, 2019-2027

Schedule a Call